Anita Y. Szajek PhD

Dr. Anita Szajek received her Ph.D. in bioinorganic chemistry from the University of Wisconsin in Madison, and she did postdoctoral work at Parke-Davis Pharmaceuticals and NIH National Cancer Institute on matrix metalloproteinases. She then joined Emergent BioSolutions as a scientist working to develop diagnostics, vaccines, and pharmaceuticals for chronic bacterial infections and infectious diseases.

She subsequently joined Human Genome Sciences as a senior scientist focused on purification process development activities, scale-up, and analytical assay development from preclinical to Phase III. Dr. Szajek next moved to United States Pharmacopeia, where she served as a principal scientific liaison for over 10 years. She worked closely with FDA and WHO to develop public standards for heparins, blood products, proteins, and synthetic peptides.